Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grupo Scheffer is a leading Brazilian agribusiness and life sciences company specializing in large-scale regenerative agriculture and agricultural biotechnology. The company is a pioneer in the development and application of biological inputs, operating a sophisticated 'Biofábrica' (biofactory) to produce microbial-based biopesticides and biofertilizers. These biological solutions are designed to replace traditional chemical treatments, enhancing soil biodiversity and crop resilience across their production of cotton, soybeans, and corn. By integrating advanced biotechnology into field operations, Scheffer has established itself as a benchmark for sustainable, low-carbon farming practices in South America. Their business model focuses on the circular economy of soil health, utilizing live biotherapeutic products to optimize agricultural yields while reducing environmental impact.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grupo Scheffer.